Market Share of Global Stroke Therapeutics Industry
The stroke therapeutics market is fragmented, competitive, and consists of several major players. Patent expiry of major drugs is responsible for the entry of several generic drugs into the market, and thereby competition in the market increases. AstraZeneca, Amgen Inc., Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Merck and Co. Inc., Johnson and Johnson Inc., Pfizer Inc., Sanofi SA, Daiichi Sankyo Company, Limited, and Biogen Inc. are some of the key operating players in the stroke therapeutics market.
Stroke Therapeutics Market Leaders
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
F. Hoffmann La Roche Ltd.
Johnson & Johnson
Pfizer Inc
*Disclaimer: Major Players sorted in no particular order
